Table 1 Demographic and behavioural information of the study participants in the final analysis for post-infectious ME/CFS (PI-ME/CFS) group.
Characteristics | PI-ME/CFS participants (n = 43) | Healthy controls (HCs, n = 43) | p values |
|---|---|---|---|
Female/male | 37/6 | 37/6 | n/a |
Age (years) | 42.58 ± 12.41 [24, 65] | 40.19 ± 8.29 [19, 58] | 0.67 |
BMI (kg/m2) | 25.16 ± 4.16 [17.18, 34.66] | 25.51 ± 4.33 [17.36, 35.38] | 0.82 |
MET rate | 1.29 ± 0.14 [1.04, 1.74] | 1.32 ± 0.14 [1, 1.60] | 0.10 |
MRI scan time | 11.81 ± 1.72 [8.05, 15.60] | 11.61 ± 1.75 [7.43, 16.10] | 0.55 |
HADS-anxiety | 7.40 ± 4.01 [0, 15] | 4.51 ± 2.87 [0, 14] | < 0.001 |
HADS-depression | 6.21 ± 3.80 [0, 16] | 2.00 ± 2.69 [0, 11] | < 0.001 |
SF-36 - MCS | 44.52 ± 7.03 [30.29, 58.09] | 53.02 ± 5.60 [38.57, 60.36] | < 0.001 |
SF-36 - PCS | 35.87 ± 9.98 [15.83, 57.23] | 58.46 ± 7.23 [35.43, 68.30] | < 0.001 |
Global PSQI | 9.15 ± 3.32 [2, 17] | 4.91 ± 3.35 [0, 14] | < 0.001 |
BDS | 42.56 ± 15.44 [20, 90] | 95.12 ± 11.42 [50, 100] | < 0.001 |
Disease severity | 3.12 ± 1.26 [1, 5] | n/a | n/a |
Disease duration (years) | 13.51 ± 10.60 [0.75, 45] | n/a | n/a |